Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125056733 | 12505673 | 3 | F | 20160704 | 20160628 | 20160713 | EXP | US-009507513-1606USA011371 | MERCK | 72.00 | YR | F | Y | 0.00000 | 20160713 | CN | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125056733 | 12505673 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | INITIAL TREATMENT | 12675 | TABLET | |||||||||
| 125056733 | 12505673 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | REGIMEN REINITIATED AFTER RELAPSE | 12675 | TABLET | |||||||||
| 125056733 | 12505673 | 3 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | INITIAL TREATMENT | 0 | |||||||||||
| 125056733 | 12505673 | 4 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | REGIMEN REINITIATED AFTER RELAPSE | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125056733 | 12505673 | 1 | Plasma cell myeloma |
| 125056733 | 12505673 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125056733 | 12505673 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125056733 | 12505673 | Pneumonia | |
| 125056733 | 12505673 | Syncope | |
| 125056733 | 12505673 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |